Jon S. Zawistowski

3.0k total citations
28 papers, 1.5k citations indexed

About

Jon S. Zawistowski is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Jon S. Zawistowski has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Oncology. Recurrent topics in Jon S. Zawistowski's work include Protein Degradation and Inhibitors (7 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Vascular Malformations Diagnosis and Treatment (6 papers). Jon S. Zawistowski is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Vascular Malformations Diagnosis and Treatment (6 papers). Jon S. Zawistowski collaborates with scholars based in United States, Switzerland and Italy. Jon S. Zawistowski's co-authors include Gary L. Johnson, Douglas A. Marchuk, Nicholas W. Plummer, Steven P. Angus, Amy N. Abell, Timothy J. Stuhlmiller, Lee M. Graves, Brooke B. Ancrile, Mark Uhlik and Noah Sciaky and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Molecular and Cellular Biology.

In The Last Decade

Jon S. Zawistowski

26 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon S. Zawistowski United States	17	666	603	206	157	133	28	1.5k
Shizhen Zhu United States	16	392 0.6×	716 1.2×	154 0.7×	275 1.8×	257 1.9×	38	1.1k
Bryan W. Johnson United States	8	193 0.3×	738 1.2×	326 1.6×	102 0.6×	108 0.8×	15	1.1k
Evon Poon United Kingdom	14	334 0.5×	789 1.3×	303 1.5×	173 1.1×	338 2.5×	24	1.1k
Flora Cimmino Italy	20	482 0.7×	511 0.8×	233 1.1×	50 0.3×	370 2.8×	33	1.1k
Roberto Tonelli Italy	19	287 0.4×	677 1.1×	230 1.1×	37 0.2×	221 1.7×	42	1.1k
Barbara Tanno Italy	19	190 0.3×	737 1.2×	423 2.1×	61 0.4×	268 2.0×	45	1.1k
Allie H. Grossmann United States	19	199 0.3×	753 1.2×	344 1.7×	134 0.9×	171 1.3×	38	1.4k
Carmel McConville United Kingdom	23	212 0.3×	939 1.6×	385 1.9×	71 0.5×	467 3.5×	55	1.4k
Mara P. Steinkamp United States	14	277 0.4×	297 0.5×	160 0.8×	41 0.3×	102 0.8×	26	894
Walter J. Jessen United States	16	420 0.6×	471 0.8×	100 0.5×	75 0.5×	77 0.6×	20	951

Countries citing papers authored by Jon S. Zawistowski

Since Specialization

Citations

This map shows the geographic impact of Jon S. Zawistowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon S. Zawistowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon S. Zawistowski more than expected).

Fields of papers citing papers by Jon S. Zawistowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon S. Zawistowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon S. Zawistowski. The network helps show where Jon S. Zawistowski may publish in the future.

Co-authorship network of co-authors of Jon S. Zawistowski

This figure shows the co-authorship network connecting the top 25 collaborators of Jon S. Zawistowski. A scholar is included among the top collaborators of Jon S. Zawistowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon S. Zawistowski. Jon S. Zawistowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goulet, Daniel R., Jon S. Zawistowski, Samantha M. Bevill, et al.. (2020). Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer. Molecular Cancer Research. 18(11). 1685–1698. 3 indexed citations

Bevill, Samantha M., Noah Sciaky, Brian T. Golitz, et al.. (2019). GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer. Molecular Cancer Research. 17(7). 1503–1518. 44 indexed citations

Bevill, Samantha M., Noah Sciaky, Brian T. Golitz, et al.. (2018). Abstract B34: Novel synergistic combination therapies with BET bromodomain inhibitors in triple-negative breast cancer. Molecular Cancer Research. 16(8_Supplement). B34–B34. 1 indexed citations

Zawistowski, Jon S., et al.. (2017). MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal Transition. Cell Reports. 18(10). 2387–2400. 48 indexed citations

Angus, Steven P., Jon S. Zawistowski, & Gary L. Johnson. (2017). Epigenetic Mechanisms Regulating Adaptive Responses to Targeted Kinase Inhibitors in Cancer. The Annual Review of Pharmacology and Toxicology. 58(1). 209–229. 19 indexed citations

Stuhlmiller, Timothy J., Samantha M. Miller, Jon S. Zawistowski, et al.. (2015). Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains. Cell Reports. 11(3). 390–404. 209 indexed citations

Zawistowski, Jon S., Lee M. Graves, & Gary L. Johnson. (2014). Assessing adaptation of the cancer kinome in response to targeted therapies. Biochemical Society Transactions. 42(4). 765–769. 10 indexed citations

Allen, Richard J., Denis Tsygankov, Jon S. Zawistowski, Timothy C. Elston, & Klaus M. Hahn. (2013). Automated line scan analysis to quantify biosensor activity at the cell edge. Methods. 66(2). 162–167. 4 indexed citations

Zawistowski, Jon S., Kazuhiro Nakamura, Joel S. Parker, et al.. (2013). MicroRNA 9-3p Targets β₁ Integrin To Sensitize Claudin-Low Breast Cancer Cells to MEK Inhibition. Molecular and Cellular Biology. 33(11). 2260–2274. 48 indexed citations

10.

Zawistowski, Jon S., Mohsen Sabouri-Ghomi, Gaudenz Danuser, Klaus M. Hahn, & Louis Hodgson. (2013). A RhoC Biosensor Reveals Differences in the Activation Kinetics of RhoA and RhoC in Migrating Cells. PLoS ONE. 8(11). e79877–e79877. 39 indexed citations

11.

Whittle, Martin C., James S. Duncan, Amy N. Abell, et al.. (2012). Defining the expressed breast cancer kinome. Cell Research. 22(4). 620–623. 19 indexed citations

12.

Shadpour, Hamed, et al.. (2011). Patterning pallet arrays for cell selection based on high-resolution measurements of fluorescent biosensors. Analytica Chimica Acta. 696(1-2). 101–107. 5 indexed citations

13.

Nakamura, Kazuhiro, Jon S. Zawistowski, Mark Hughes, et al.. (2008). Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer Assay for Measurement of Phox/Bem1p (PB1) Domain Heterodimerization. SLAS DISCOVERY. 13(5). 396–405. 3 indexed citations

14.

Plummer, Nicholas W., Teresa L. Squire, Sudha Srinivasan, et al.. (2006). Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mammalian Genome. 17(2). 119–128. 50 indexed citations

15.

Plummer, Nicholas W., Jon S. Zawistowski, & Douglas A. Marchuk. (2005). Genetics of cerebral cavernous malformations. Current Neurology and Neuroscience Reports. 5(5). 391–396. 48 indexed citations

16.

Zawistowski, Jon S., Mark Uhlik, Amy N. Abell, et al.. (2005). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Human Molecular Genetics. 14(17). 2521–2531. 199 indexed citations

17.

Plummer, Nicholas W., Carol J. Gallione, Sudha Srinivasan, et al.. (2004). Loss of p53 Sensitizes Mice with a Mutation in Ccm1 (KRIT1) to Development of Cerebral Vascular Malformations. American Journal Of Pathology. 165(5). 1509–1518. 89 indexed citations

18.

Liquori, Christina L., Michel J. Berg, Adrian M. Siegel, et al.. (2003). Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous Malformations. The American Journal of Human Genetics. 73(6). 1459–1464. 261 indexed citations

19.

Zawistowski, Jon S.. (2002). KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Human Molecular Genetics. 11(4). 389–396. 156 indexed citations

20.

Kniazeva, Marina, Jon S. Zawistowski, & Min Han. (1998). Addition of second primer after initial denaturation step in PCR cycling: a simple way to avoid low-molecular-weight non-specific products. 3(1). 73–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact